J Korean Med Sci.  2020 Jun;35(24):e224. 10.3346/jkms.2020.35.e224.

Financial Burden of Hospitalization of Children with Coronavirus Disease 2019 under the National Health Insurance Service in Korea

• Lee JK
• Kwak BO
• Choi JH
• Choi EH
• Kim JH
• Kim DH

• KMID: 2503017
• DOI: http://doi.org/10.3346/jkms.2020.35.e224

Abstract

Coronavirus disease 2019 (COVID-19) has resulted in an ongoing pandemic; however, the socioeconomic burden of COVID-19 treatment in the pediatric population remains unclear. Thus, the aim of this study was to determine the hospitalization periods and medical costs among children with COVID-19. In total, 145 billing statements for pediatric patients receiving healthcare services because of COVID-19 from February 1, 2020 to March 31, 2020 were used. The study showed that individual treatment costs for children with COVID-19 are approximately USD 2,192 under the Korean National Health Insurance Service System. This study revealed the differences in cost among age groups, determined by the type of hospital wherein admission occurred, as a trend of increasing age, increasing hospitalization time, and increasing cost was observed. Tailored COVID-19 treatment strategies by age group may lower costs and increase the effectiveness of resource allocation.

Keyword

Coronavirus disease; Severe Acute Respiratory Syndrome Coronavirus 2; Costs and Cost Analysis; Insurance; Pediatrics

Reference

1. Choi SH, Kim HW, Kang JM, Kim DH, Cho EY. Epidemiology and clinical features of coronavirus disease 2019 in children. Clin Exp Pediatr. 2020; 63(4):125–132. PMID: 32252139.

2. Korea Centers for Disease Control and Prevention. Coronavirus disease-19, Republic of Korea: updates on COVID-19 in Republic of Korea. As of May 6, 2020;Updated 2020. Accessed May 6, 2020. http://ncov.mohw.go.kr/board/doFileDownload.do?file_name=Press_Release_(May_05)_Afternoon.pdf&file_path=/upload/ncov/file/202005/1588730480383_20200506110120.pdf&seq=3906.

3. Seong SC, Kim YY, Khang YH, Heon Park J, Kang HJ, Lee H, et al. Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017; 46(3):799–800. PMID: 27794523.

4. Korea Centers for Disease Control and Prevention. Infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings. Updated 2020. Accessed May 6, 2020. http://ncov.mohw.go.kr/duBoardList.do?brdId=2&brdGubun=28.

5. Ministry of Health and Welfare. Health Insurance Review and Assessment Service #opendata4covid19. Updated 2020. Accessed May 6, 2020. https://hira-covid19.net.

6. King JC Jr, Burke AR, Clemens JD, Nair P, Farley JJ, Vink PE, et al. Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children. Pediatr Infect Dis J. 1993; 12(9):733–739. PMID: 8414800.

7. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. Forthcoming. 2020; DOI: 10.1001/jamapediatrics.2020.1467.

8. Maekyung Media Group. COVID-19 treatment in Korea cost $57,562 per critically-ill, bill charged on state. Updated 2020. Accessed May 8, 2020. https://pulsenews.co.kr/view.php?sc=30800022&year=2020&no=471089.

9. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020; 382(17):1663–1665. PMID: 32187458.